Related Experiment Video

Updated: Aug 10, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

[Chlamydia pneumoniae and vascular pathology]

M C Maroto Vela

    Anales De La Real Academia Nacional De Medicina
    |February 24, 2001
    PubMed

    Insights

    Chlamydia pneumoniae may contribute to atheromatous plaque formation. PCR detected this bacterium in high percentages in vascular biopsies, questioning its pathogenic role in vascular disease.

    Area of Science:

    • Microbiology
    • Immunology
    • Vascular Pathology

    Background:

    • This study updates the microbiological and diagnostic features of Chlamydia pneumoniae.
    • It investigates the bacterium's potential role in atheromatous plaque development.
    • Immunological data from patient groups with vascular pathology, pneumonia, or genital infections were analyzed.

    Discussion:

    • Chlamydia pneumoniae was identified via PCR in a significant proportion of vascular biopsies.
    • Detection rates were particularly high in carotid artery (74%) and aortic wall (83%) samples.
    • The findings raise questions about the definitive pathogenic power of Chlamydia in vascular conditions.

    Key Insights:

    • High prevalence of Chlamydia pneumoniae detected in atheromatous plaque samples.
    • Correlation between C. pneumoniae presence and peripheral vascular pathology.
    • Need for further research to elucidate the causal link between C. pneumoniae and atherosclerosis.

    Outlook:

    • Further investigation into the pathogenic mechanisms of Chlamydia pneumoniae in vascular disease is warranted.
    • Exploring novel diagnostic and therapeutic strategies targeting Chlamydia in atherosclerosis.
    • Understanding the interplay between microbial agents and cardiovascular health.

    More Related Videos

    Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells07:42

    Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

    Published on: October 13, 2015

    Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

    Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

    Published on: April 7, 2015

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

    Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

    Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...